Browsing by Author Greil, Richard
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Jan-2014 | MDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysis | Benner, Axel; Mansouri, Larry; Rossi, Davide; Majid, Aneela; Willander, Kerstin; Parker, Anton; Bond, Gareth; Pavlova, Sarka; Nückel, Holger; Merkel, Olaf; Ghia, Paolo; Montserrat Costa, Emilio; Kaderi, Mohd Arifin; Rosenquist, Richard; Gaidano, Gianluca; Dyer, Martin J. S.; Söderkvist, Peter; Linderholm, Mats; Oscier, David; Tvaruzkova, Zuzana; Pospisilova, Sarka; Dührsen, Ulrich; Greil, Richard; Döhner, Hartmut; Stilgenbauer, Stephan; Zenz, Thorsten |
| May-2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048 | Rischin, Danny; Harrington, Kevin J.; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Hong, Ruey-Long; González Mendoza, René; Jia, Liyi; Chirovsky, Diana; Norquist, Josephine; Jin, Fan; Burtness, Barbara |
| 1-May-2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048 | Rischin, Danny; Harrington, Kevin J.; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Hong, Ruey-Long; Gonzalez Mendoza, René; Jia, Liyi; Chirovsky, Diana; Norquist, Josephine; Jin, Fan; Burtness, Barbara |
| 20-Jul-2022 | Pembrolizumab alone or with chemotherapy for recurrent/metastatic head and neck squamous cell carcinoma in KEYNOTE-048: subgroup analysis by Programmed Death Ligand-1 combined positive score | Burtness, Barbara; Rischin, Danny; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Ge, Joy; Swaby, Ramona F.; Gumuscu, Burak; Harrington, Kevin J. |
| 11-Oct-2022 | Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study | Harrington, Kevin J.; Burtness, Barbara; Greil, Richard; Soulières, Denis; Tahara, Makoto; Castro, Gilberto de; Psyrri, Amanda; Braña, Irene; Basté, Neus; Neupane, Prakash; Bratland, Åse; Fuereder, Thorsten; Hughes, Brett G.M.; Mesía Nin, Ricard; Ngamphaiboon, Nuttapong; Rordorf, Tamara; Ishak, Wan Zamaniah Wan; Lin, Jiaxin; Gumuscu, Burak; Swaby, Ramona F.; Rischin, Danny |